iScore AD

Published by: SWISS4WARD EUROPE SL
Downloads
Revenue

Description

Die Bestimmung der Krankheitsaktivität beim atopischen Ekzem ist sehr zeitaufwändig, wird aber immer wichtiger zur Rechtfertigung der Therapie-Kosten gegenüber den Krankenkassen. Die vorliegende App erlaubt die Bestimmung des EASI (Eczema Area and Severity Index) innerhalb von 15 Sekunden.

Screenshots

iScore AD FAQ

  • Is iScore AD free?

    Yes, iScore AD is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is iScore AD legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does iScore AD cost?

    iScore AD is free.

  • What is iScore AD revenue?

    To get estimated revenue of iScore AD app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Dominican Republic yet.
Ratings History

iScore AD Reviews

No English!

twaustralia on

Australia

The app is no longer in English! Please restore this if possible. Thank you very much.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
266

iScore AD Competitors

Name
EczemaLess Asistente de eccema
Controla tu eccema
Eczema CARE+
Pilates Workout Routines
Tone & Strengthen at Home
handyscope pro
YOUdermoscopy
Side Onco Skin
EASI-SCORAD
Dermatitis Atópica
CRUSE Control Urticaria
e-Derma Solutions
Hautkonsil per Telemedizin
E-burn Premium

iScore AD Installs

Last 30 days

iScore AD Revenue

Last 30 days

iScore AD Revenue and Downloads

Gain valuable insights into iScore AD performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.